Your browser doesn't support javascript.
loading
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines.
Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander; Knoll, Verena; Espin, Jaime; Mantel-Teeuwisse, Aukje K; Panteli, Dimitra; Suleman, Fatima; Wirtz, Veronika J; Babar, Zaheer-Ud-Din.
Afiliação
  • Vogler S; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, Austria.
  • Zimmermann N; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, Austria.
  • Haasis MA; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, Austria.
  • Knoll V; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH, Vienna, Austria.
  • Espin J; Andalusian School of Public Health, Granada, Spain.
  • Mantel-Teeuwisse AK; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the Netherlands.
  • Panteli D; European Observatory on Health Systems and Policies, Brussels, Belgium.
  • Suleman F; WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Wirtz VJ; WHO Collaborating Center in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health, Boston, USA.
  • Babar ZU; Department of Pharmacy, University of Huddersfield, UK.
J Pharm Policy Pract ; 17(Suppl 1): 2335492, 2024.
Article em En | MEDLINE | ID: mdl-38757122
ABSTRACT
Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands Strand 1 on 'Local challenges, global learnings' aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on 'Strengthening the evidence base' is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 'Futureproofing pharmaceutical policies' is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article